Bo Ram Kang

Bo Ram Kang

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2009 in International Journal of Peptides
Verified
Journal Article
Open access
PDF file
JHJae-Sam Hwang
Jae-Sam Hwang
JLJuneyoung Lee
Juneyoung Lee
YKYeon-Ju Kim
Yeon-Ju Kim
HBHea-Son Bang
Hea-Son Bang
EYEun-Young Yun
Eun-Young Yun
DLDong Gun Lee
Dong Gun Lee
The antibacterial activity of immune-related peptides, identified by a differential gene expression analysis, was investigated to suggest novel antibacterial peptides. A cDNA encoding a defensin-like peptide, Coprisin, was isolated from bacteria-immunized dung beetle,Copris tripartitus, by using differential dot blot hybridization. Northern blot analysis showed that Coprisin mRNA was up-regulated from 4 hours after bacteria injection and its expression level was reached a peak at 16 hours. The deduced amino acid sequence of Coprisin was composed of 80 amino acids with a predicted molecular weight of 8.6 kDa and a pI of 8.7. The amino acid sequence of mature Coprisin was found to be 79.1% and 67.4% identical to those of defensin-like peptides ofAnomala cupreaandAllomyrina dichotoma, respectively. We also investigated active sequences of Coprisin by using amino acid modification. The result showed that the 9-mer peptide, LLCIALRKK-NH2, exhibited potent antibacterial activities againstEscherichia coliandStaphylococcus aureus.

7 October 2016 in Scientific Reports
Verified
Journal Article
Open access
BKBo Ram Kang
Bo Ram Kang
SYSeung-Hoon Yang
Seung-Hoon Yang
BCBo-Ryehn Chung
Bo-Ryehn Chung
WKWoong Kim
Woong Kim
YoungSoo KimYoungSoo Kim
YoungSoo Kim
High-grade glioma is a highly malignant and metastatic brain cancer, resistant to many existing anticancer treatments. In such glioma cancer cells, the glucose-regulated protein 78 kDa (GRP78) is particularly highly up-regulated. Former studies have thus targeted mutation-free GRP78 not only to detect glioma cancer cells specifically but also to enhance cytotoxic effect. We focus on cell surface-expressed GRP78 as a target for suppressing high-grade glioma cell lines. Glioblastoma multiforme (GBM) cell line, highly malignant glioma cells, was first injected into 5-week-old athymic mice to confirm and compare GRP78 expression in vivo in xenografted and normal brain tissue. Immunofluorescence and immunoblotting were utilized to detect surface-localized GRP78 in diverse high-grade glioma cell lines. By treating glioma cell lines with the polyclonal N-20 antibody against surface-localized GRP78, we subsequently studied the significance of surface GRP78 to the survival and growth of the glioma cell lines. We found that inhibiting the function of surface GRP78 suppressed cancer cell survival and growth proving that the surface-expressed GRP78 is a vital receptor involved in the proliferation of high-grade glioma. Our findings provide opportunities to target surface GRP78 as a biomarker for high-grade glioma and to develop effective cell-specific anticancer therapy.

29 February 2012 in BMB Reports
Verified
Journal Article
Open access
BKBo Ram Kang
Bo Ram Kang
HKHo Kim
Ho Kim
SNSung-Hee Nam
Sung-Hee Nam
EYEun-Young Yun
Eun-Young Yun
SKSeong-Ryul Kim
Seong-Ryul Kim
JHJae-Sam Hwang
Jae-Sam Hwang
Our previous study demonstrated that CopA3, a disulfide dimer of the coprisin peptide analogue (LLCIALRKK), has antibacterial activity. In this study, we assessed whether CopA3 caused cellular toxicity in various mammalian cell lines. CopA3 selectively caused a marked decrease in cell viability in Jurkat T, U937, and AML-2 cells (human leukemia cells), but was not cytotoxic to Caki or Hela cells. Fragmentation of DNA, a marker of apoptosis, was also confirmed in the leukemia cell lines, but not in the other cells. CopA3-induced apoptosis in leukemia cells was mediated by apoptosis inducing factor (AIF), indicating induction of a caspase-independent signaling pathway.

11 February 2019 in Cells
Verified
Journal Article
Open access
PDF file
JLJi Hae Lee
Ji Hae Lee
JSJee Young Sung
Jee Young Sung
ECEun Kyung Choi
Eun Kyung Choi
HYHyun-Kyoung Yoon
Hyun-Kyoung Yoon
BKBo Ram Kang
Bo Ram Kang
KYKyungsil Yoon
Kyungsil Yoon
The CCAAT/enhancer-binding protein β (C/EBPβ) is a transcription factor that regulates cellular proliferation, differentiation, apoptosis and tumorigenesis. Although the pro-oncogenic roles of C/EBPβ have been implicated in various human cancers, how it contributes to tumorigenesis or tumor progression has not been determined. Immunohistochemistry with human non-small cell lung cancer (NSCLC) tissues revealed that higher levels of C/EBPβ protein were expressed compared to normal lung tissues. Knockdown of C/EBPβ by siRNA reduced the proliferative capacity of NSCLC cells by delaying the G2/M transition in the cell cycle. In C/EBPβ-knockdown cells, a prolonged increase in phosphorylation of cyclin dependent kinase 1 at tyrosine 15 (Y15-pCDK1) was displayed with simultaneously increased Wee1 and decreased Cdc25B expression. Chromatin immunoprecipitation (ChIP) analysis showed that C/EBPβ bound to distal promoter regions of WEE1 and repressed WEE1 transcription through its interaction with histone deacetylase 2. Treatment of C/EBPβ-knockdown cells with a Wee1 inhibitor induced a decrease in Y15-pCDK1 and recovered cells from G2/M arrest. In the xenograft tumors, the depletion of C/EBPβ significantly reduced tumor growth. Taken together, these results indicate that Wee1 is a novel transcription target of C/EBPβ that is required for the G2/M phase of cell cycle progression, ultimately regulating proliferation of NSCLC cells.

4 February 2015 in Journal of the Korean Society for Applied Biological Chemistry
Verified
Journal Article
Closed access
PDF file
WKWoong Kim
Woong Kim
BKBo Ram Kang
Bo Ram Kang
HKHye Yun Kim
Hye Yun Kim
SCSoo Min Cho
Soo Min Cho
YLYong-Deok Lee
Yong-Deok Lee
YoungSoo KimYoungSoo Kim
YoungSoo Kim

21 January 2019 in Preprints.org
Verified
Preprint
Open access
JLJi Hae Lee
Ji Hae Lee
JSJeeyoung Sung
Jeeyoung Sung
ECEun Kyung Choi
Eun Kyung Choi
HYHyun-Kyoung Yoon
Hyun-Kyoung Yoon
BKBo Ram Kang
Bo Ram Kang
KYKyungsil Yoon
Kyungsil Yoon
The CCAAT/enhancer-binding protein β (C/EBPβ) is a transcription factor that regulates cellular proliferation, differentiation, apoptosis and tumorigenesis. Although the pro-oncogenic roles of C/EBPβ have been implicated in various human cancers, how it contributes to tumorigenesis or tumor progression has not been determined. Immunohistochemistry with human non-small cell lung cancer (NSCLC) tissues revealed that higher levels of C/EBPβ protein are expressed compared to normal lung tissues. Knockdown of C/EBPβ by siRNA reduced the proliferative capacity of NSCLC cells by delaying G2/M transition of the cell cycle. In C/EBPβ-knockdown cells, a prolonged increase in phosphorylation of cyclin dependent kinase 1 at tyrosine 15 (Y15-pCDK1) was displayed with increased Wee1 and decreased Cdc25B expression, simultaneously. ChIP analysis showed that C/EBPβ bound to distal promoter regions of WEE1 and repressed WEE1 transcription through the interaction with histone deacetylase 2. Treatment of C/EBPβ-knockdown cells with a Wee1 inhibitor induced a decrease in Y15-pCDK1 and recovered cells from G2/M arrest. In the xenograft tumors, the depletion of C/EBPβ significantly reduced tumor growth. Taken together, these results indicate that Wee1 is a novel transcription target of C/EBPβ that is required for the G2/M phase of cell cycle progression, ultimately regulating proliferation of NSCLC cells.